Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system☆
Section snippets
Introduction: opportunities and challenges
There is general consensus in the pharmaceutical industry that poorly water-soluble drug candidates are becoming more prevalent (Lipinski et al., 1997, Lipinski, 2000). If a drug candidate has reasonable membrane permeability then often the rate-limiting process of absorption is the drug dissolution step. This is characteristic of compounds which can be categorised as biopharmaceutical classification system (BCS) class II (Yu et al., 2002). Formulation plays a major role in determining the rate
Dispersion, digestion and metastability
Many amorphous solid solutions or lipid systems contain a considerable proportion of water-soluble excipients, such as water-soluble polymers (e.g. PVP, PEG), low molecular weight cosolvents (ethanol, propylene glycol, PEG 400, transcutol, etc.) or hydrophilic surfactants (polysorbate 80, ethoxylated triglycerides, etc.). The polymers and cosolvents are particularly prone to causing drug precipitation on dilution because the relationship between drug solubility and cosolvent concentration
Digestion and solubilization in the small intestine
The solubilization capacity of the digestive system is considerable and its presence has an effect on the dissolution and absorption of lipophilic drugs from all formulations (Embleton and Pouton, 1997). The solubilising power is greater after a fatty meal, hence, food often has a positive effect on bioavailability of dissolution rate-limited BCS class II drugs. Bile salt concentrations in the gut are 3–5 mM on a fasted stomach and approximately 15 mM after food. Formulae for simulation of
Amorphous formulations
Amorphous formulations, such as ‘solid dispersions’ may allow drugs to disperse as supersaturated solutions, at least temporarily, but eventually the drug will relax into its most thermodynamically favourable crystalline state. At present the kinetics of crystallization cannot be predicted for an individual drug, which presents the formulator with some technical problems. In some cases crystallization takes place in minutes but in others the supersaturated system may be stable for many hours.
‘Lipid’ formulations
‘Lipid’ systems have the advantage that they can present the drug as a stable liquid solution, but the term ‘lipid formulation’ has come to mean one of a large group of formulations which share some common features (Table 1). Lipid systems may include triglycerides, mono and diglycerides, lipophilic surfactants, hydrophilic surfactants and cosolvents; excipients with a wide variety of physicochemical properties. A classification system was introduced in 2000 to help identify the critical
In vitro testing of lipid formulations
In vitro tests can be used to help predict the effect of dilution and digestion, and it would be appropriate for standard tests to be defined for regulatory use. There are a number of useful tests available to the formulator. These include bile salt solubility tests, formulation dispersion/ drug precipitation tests, and in vitro digestion tests. Bile salt mixed micelle solubility is easy to determine and can give a good indication of whether the solubilising capacity of the gut will be of
Conclusions
The most significant issue to consider when formulating poorly water-soluble drugs is the threat of drug precipitation in the lumen of the gastrointestinal tract. The fate of the formulated product can be predicted using a range of in vitro tests to investigate the effects of dispersion, digestion, and gastric emptying on the fate of the drug. It would be useful to establish standard test protocols, particularly in the case of the lipolytic digestion test for lipid formulations, so that
References (28)
Melt extrusion: from process to drug delivery technology
Eur. J. Pharm. Biopharm.
(2002)- et al.
In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs
Eur. J. Pharm. Sci.
(2000) - et al.
Structure and function of gastro-intestinal lipases
Adv. Drug Deliv. Rev.
(1997) - et al.
Improving drug solubility for oral delivery using solid dispersions
Eur. J. Pharm. Biopharm.
(2000) - et al.
Influence of surfactant and lipid chain length on the solubilization of phosphatidylcholine vesicles by micelles comprised of polyoxyethylene sorbitan monoesters
Colloids Surf. A: Physicochem. Eng. Asp.
(2004) Drug-like properties and the causes of poor solubility and poor permeability
J. Pharmacol. Toxicol. Methods
(2000)- et al.
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Adv. Drug Deliv. Rev.
(1997) - et al.
Influence of lipoplysis on drug absorption from the gastrointestinal tract
Adv. Drug Deliv. Rev.
(1997) - et al.
Nanosizing: a formulation approach for poorly water-soluble compounds
Eur. J. Pharm. Sci.
(2003) - et al.
Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine
J. Pharm. Sci.
(2004)
Lipid formulations for oral administration of drugs: non-emulsifying, self emulsifying and ‘self microemulsifying’ drug delivery systems.
Eur. J. Pharm. Sci.
Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs
J. Pharm. Sci.
A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium
Eur. J. Pharm. Sci.
A dynamic in vitro lipolysis model. II. Evaluation of the model
Eur. J. Pharm. Sci.
Cited by (1064)
Development of lipid-based SEDDS using digestion products of long-chain triglyceride for high drug solubility: Formulation and dispersion testing
2024, International Journal of PharmaceuticsDevelopment of a self-nanoemulsifying drug delivery system of diindolylmethane for enhanced bioaccessibility, bioavailability and anti-breast cancer efficacy
2024, Journal of Drug Delivery Science and TechnologyEarly evaluation of opportunities in oral delivery of PROTACs to overcome their molecular challenges
2024, Drug Discovery TodayThe effect of polymeric binder type and concentration on flow and dissolution properties of SMEDDS loaded mesoporous silica-based granules
2024, European Journal of Pharmaceutical SciencesCharacterization and bioactivity of copaiba essential oil carried in a self-nanoemulsifying drug delivery system
2024, Journal of Drug Delivery Science and TechnologyDigestion is a critical element for absorption of cinnarizine from supersaturated lipid-based type I formulations
2024, European Journal of Pharmaceutical Sciences
- ☆
This paper was presented in an earlier form at the Gattefosse Academie des Alpilles, June 2005, St. Remy, France.